Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer

In two data sets, the tumor chemosensitivity assessed by the KELIM (online calculator)<sup>29</sup> was a consistent significant predictor of three critical outcomes associated with successful ICS after NACT. The radiologic response was inconsistently associated with lower disease bulk. The <i>BRCA</i>/HRD status was not predictive of NACT efficacy. These outcomes may inform decisions and future chemosensitizing innovative strategies.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-11-24
DOI
https://doi.org/10.1200/op-25-00469
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer

Aurore Carrot, Umberto Malapelle, Félix Blanc‐Durand, Alexandra Léary et al.
JCO Oncology Practice
Ovarian cancer diagnosis and treatment
article

Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer

Aurore Carrot, Umberto Malapelle, Félix Blanc‐Durand, Alexandra Léary, Olivier Colomban, Carolina Maria Sassu, Gwénaël Ferron, Pierre Combe, Domenica Lorusso, Filippo Maria Capomacchia, Alain Lortholary, Éric Pujade-Lauraine, Isabelle Laure Ray-Coquard, Cláudia Marchetti, Benoît You, Anna Fagotti, Adriana Ionelia Apostol, Raffaella Ergasti, Diana Giannarelli, Giovanni Scambia, Gian Franco Zannoni, Pierre-Alexandre Just
article en

Abstract

In two data sets, the tumor chemosensitivity assessed by the KELIM (online calculator)<sup>29</sup> was a consistent significant predictor of three critical outcomes associated with successful ICS after NACT. The radiologic response was inconsistently associated with lower disease bulk. The <i>BRCA</i>/HRD status was not predictive of NACT efficacy. These outcomes may inform decisions and future chemosensitizing innovative strategies.

JCO Oncology Practice
Université Claude Bernard Lyon 1 (FR), Università Cattolica del Sacro Cuore (IT), Lyon College (US), Institut Gustave Roussy (FR), Agostino Gemelli University Polyclinic (IT), Assistance Publique Hôpitaux de Marseille (FR), Hospices Civils de Lyon (FR), Hôpital Européen Georges-Pompidou (FR), Centre Léon Bérard (FR), Hôpital Européen (FR), Institut Claudius Regaud (FR), Arcagy Gineco (FR), Hôpital privé du Confluent (FR), Eau de Paris (France) (FR), University of Naples Federico II (IT), HCL Technologies (India) (IN)
Openalex Percentile: Top 54%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.